Envelope, capsid, and soluble antigens of Herpesvirus hominis (HVH) types 1 and 2 were compared to crude antigens (disrupted HVH-infected cells) for potency, type-specificity, and diagnostic value in the indirect hemagglutination (IHA) 
The envelope, capsid, and soluble antigens of Herpesuirus hominis (HVH) types 1 and 2 have been studied by Martin et al. (4) in the complement fixation (CF) test using immune animal and human sera. Their major findings were the following: (i) all three of the subunit antigens showed cross-reactivity between HVH types 1 and 2; (ii) animals immunized with crude HVH preparations produced high levels of CF antibody to the soluble antigens, but humans convalescing from natural infections showed little or no reactivity with the soluble antigens; and (iii) CF antibody levels to capsid antigens were higher than those to envelope antigens in healthy humans without evidence of current HVH infections, but titers to envelope antigens were higher in sera of humans recovering from herpetic infections.
The present studies were undertaken to determine which of the HVH subunit antigens were the most potent sensitizing antigens for In general, the subunit antigens all gave lower IHA antibody titers, both homotypic and het- Thus, it is difficult to clearly delineate the extent of heterotypic reactivity of subunit antigens using animal or human sera unless sera from a number of different individuals are employed. It appears that the envelope component of HVH is the predominant one reacting in the IHA test; however, with repeated herpesvirus infections, human sera tended to show relatively high antibody titers with homologous and heterologous capsid antigens. The results of these studies would indicate that both common and type-specific HVH antigens are present in the envelope, and perhaps in the capsid, and the development of antigens for direct typing of HVH antibodies will depend upon further separation of the specific type 1 and type 2 components from the common antigens.
